ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

ICU vs NMTC // EV/EBITDA & P/E VALUATION

SeaStar Medical Holding Corporation (NASDAQ) VS. NeuroOne Medical Technologies Corporation (NASDAQ) • 15-METRIC TALLY: ICU 3 — NMTC 4
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ICU VS. NMTC) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC ICU NMTC SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 95.70% 56.50% +39.20 ICU /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% -35.00% 0.00 TIE /roic <GO>
EV/EBITDA & P/E Valuation ACTIVE — — — TIE /valuation <GO>
Free Cash Flow Yield — — — TIE /fcf-yield <GO>
Operating Margin -60.00% -46.50% -13.50 NMTC /operating-margins <GO>
Net Profit Margin -60.00% -39.60% -20.40 NMTC /net-margins <GO>
Revenue Growth (YoY) 180.00% 163.50% +16.50 ICU /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 4/9 5/9 -1.00 NMTC /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 35.4 40.1 -4.72 NMTC /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $12.2M $8.8M $3.3M ICU /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR ICU REV NMTC REV ICU GROSS % NMTC GROSS % ICU FCF NMTC FCF
FY 2025 $1.2M $9.1M 95.7% 56.5% -$13.6M -$2.9M
FY 2024 $135.0K $3.5M 98.0% 31.3% -$16.0M -$11.1M
FY 2023 $0 $2.0M — — -$10.3M -$12.9M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ICU // BETA —
NMTC // BETA —